Factor VIII Fc Fusion Protein but not FVIII Drives Human Monocyte-Derived Dendritic Cell Activation via FcγRIIa

被引:4
|
作者
Kannicht, Christoph [1 ]
Danssmann, Ilona [1 ]
Weilandt, Constanze [1 ]
Derkow, Katja [1 ]
Kohla, Guido [1 ]
Geyer, Henriette [1 ]
机构
[1] Octapharma Biopharmaceut GmbH, Mol Biochem, Walther Nernst Str 3, D-12489 Berlin, Germany
来源
HEMASPHERE | 2020年 / 4卷 / 01期
关键词
RECOMBINANT FACTOR-VIII; VON-WILLEBRAND-FACTOR; ANTIINFLAMMATORY ACTIVITY; PROLONGED ACTIVITY; RECEPTORS; IMMUNOGENICITY; MATURATION; IGG; REGULATORS; MANAGEMENT;
D O I
10.1097/HS9.0000000000000330
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study compares the effect of recombinant Factor VIII Fc fusion protein (rFVIII-Fc) with recombinant FVIII (rFVIII) on monocyte-derived dendritic cells (moDC's). Cells treated with rFVIII-Fc showed morphological changes typical for cell activation, had a significant up-regulation of cell activation markers and produced higher levels of pro-inflammatory cytokines. Even after stimulation with Lipopolysaccharides, the addition of rFVIII-Fc led to increased expression of activation markers, indicating that rFVIII-Fc is capable of amplifying the maturation signal. On the contrary, cultivation of moDC's with rFVIII did not alter cell morphology or increase surface activation marker expression and pro-inflammatory cytokine production. The binding of the Fc domain to the activating Fc gamma receptor IIa (Fc gamma RIIa) can cause cell activation. Therefore, the effect of rFVIII-Fc on Fc gamma RIIa was analyzed in detail. Cultivation of moDC's with rFVIII-Fc led to increased phosphorylation of Fc gamma RIIa, which was not detected for rFVIII. Blocking Fc gamma RIIa prior to the cultivation with rFVIII-Fc significantly reduced the activating effect of rFVIII-Fc, indicating that rFVIII-Fc-induced moDC activation was caused by Fc gamma RIIa. Moreover, rFVIII-Fc bound to FCGR2A-transfected human embryonic kidney 293 cells. Taken together, our data present a new mechanism of moDC activation by rFVIII-Fc via Fc gamma RIIa.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Physical activity in individuals with haemophilia and experience with recombinant factor VIII Fc fusion protein and recombinant factor IX Fc fusion protein for the treatment of active patients: a literature review and case reports
    Wang, Michael
    Teresa Alvarez-Roman, Maria
    Chowdary, Pratima
    Quon, Doris V.
    Schafer, Kim
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (07) : 737 - 744
  • [42] Activation of Human Monocyte-derived Dendritic Cells In Vitro by Thymax, a Gross Thymic Extract
    Ghoneum, Mamdooh
    Seto, Yoshikazu
    Agrawal, Sudhanshu
    ANTICANCER RESEARCH, 2009, 29 (11) : 4367 - 4371
  • [43] Fucosylation and Sialylation of Fc-Fragment of anti-Tumour Necrosis Factor Alpha Antibodies do not Influence Their Immunogenicity in Monocyte-Derived Dendritic Cells
    Wawrzyniak, Marcin
    Morsy, Yasser
    Mladenov, Radoslav
    Tontodonati, Giulia
    Turgay, Yagmur
    Herwig, Stefan
    Back, Jonathan
    Mally, Manuela
    Faridmoayer, Amirreza
    Scharl, Michael
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (09): : 1596 - 1601
  • [44] Expression or corticotropin releasing factor receptors on human monocyte-derived dendritic cells.
    Akagawa, E
    Takahashi, TA
    BLOOD, 2002, 100 (11) : 42B - 42B
  • [45] Induction of interleukin-10 expression through Fcα receptor in human monocytes and monocyte-derived dendritic cells: role of p38 MAPKinase
    Pilette, Charles
    Detry, Bruno
    Guisset, Amelie
    Gabriels, Julie
    Sibille, Yves
    IMMUNOLOGY AND CELL BIOLOGY, 2010, 88 (04): : 486 - 493
  • [46] Manufacturing process used to produce long-acting recombinant factor VIII Fc fusion protein
    McCue, Justin
    Kshirsagar, Rashmi
    Selvitelli, Keith
    Lu, Qi
    Zhang, Mingxuan
    Mei, Baisong
    Peters, Robert
    Pierce, Glenn F.
    Dumont, Jennifer
    Raso, Stephen
    Reichert, Heidi
    BIOLOGICALS, 2015, 43 (04) : 213 - 219
  • [47] Australian comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein (Eloctate®)
    Kershaw, Geoffrey
    Chen, Vivien M.
    Cai, Nancy
    Khoo, Teh-Liane
    HAEMOPHILIA, 2020, 26 (05) : E226 - E229
  • [48] Recombinant factor VIII Fc fusion protein (rFVIIIFc) efficacy for perioperative haemostatic management in severe haemophilia A
    Ragni, M. V.
    Chowdary, P.
    Pabinger, I.
    Feng, J.
    Lethagan, S.
    Barnowski, C.
    Mahlangu, J. N.
    HAEMOPHILIA, 2019, 25 : 9 - 9
  • [49] Development of a Bayesian estimator for a recombinant factor VIII Fc fusion protein to personalize prophylaxis for patients with haemophilia A
    Gibert, A.
    Chaux, R.
    Ollier, E.
    Delavenne, X.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 44 - 45
  • [50] Development of a Pegylated Dimeric Recombinant Factor VIII-Fc Fusion Protein for the Treatment for Hemophilia a Patients
    Liu, Bin
    Wang, Xiaoshan
    Li, Xueqin
    Yan, Haixia
    Wang, Shuya
    Zhu, Xi
    Wang, Pengju
    Gao, Jie
    Wang, Yali
    Su, Hongsheng
    BLOOD, 2018, 132